Adelaide, Australia, 6 May 2020 – GPN Vaccines is pleased to announce Dr Gladys Monroy has joined the Company’s Scientific & Advisory Board. Dr Monroy is a world-leading intellectual property lawyer with expertise in strategic counselling and comprehensive patent portfolio management in the life sciences sector....
Adelaide, Australia, 11th April 2020 – GPN Vaccines is pleased to announce it has been awarded $1 million from the South Australian Government’s Research, Commercialisation and Startup Fund (RCSF) to support a first in human clinical trial on the Company's broad-spectrum pneumonia vaccine. Established in 2019,...
Adelaide, Australia, 7 April 2020 – GPN Vaccines is pleased to announce the appointment of Dr Paul Wabnitz as the Company's Medical Director and Mr Jim Ackland as Director, Regulatory & Quality. These two appointments will significantly strengthen the clinical development team in preparation for...
Adelaide, Australia, 18 March 2020 – GPN Vaccines is pleased to announce Ms Eve Michelle Martin has been appointed as Company Secretary and General Counsel. Ms Martin will replace Dr Tim Hirst who has resigned as Company Secretary to focus on his role as Chairman & CEO...
Adelaide, Australia, 24 January 2020 – GPN Vaccines announces that it has changed its status from a Private Company limited by shares to a Public Company limited by shares and changed its name to GPN Vaccines Ltd. Shareholders at the Company’s Annual General Meeting held on Tuesday 10th...
Adelaide, Australia, 18 November 2019 – GPN Vaccines is pleased to announce Dr Lauren Giorgio has been appointed as the Company’s Chief Operating Officer. Lauren brings valuable experience in intellectual property management, business development, stakeholder engagement, commercialisation and operations in the life sciences sector, encompassing the...
GPN Vaccines selected as one of eight companies to pitch at the Startup Slam @ BIO-Europe event on 12 Nov 2019 in Hamburg....
Shannon David and Zoe Laan give presentations at the 14th European Meeting on the Molecular Biology of the Pneumococcus in Greifswald, Germany...
Tim Hirst named one of Australia’s top 50 small business leaders 2019 [https://insidesmallbusiness.com.au/planning-management/australias-top-50-small-business-leaders-2019]...
Adelaide, Australia, 21 May 2019 – Gamma-PN boosts the immune systems’ response to flu vaccination GPN Vaccines’ serotype-independent pneumococcal vaccine, Gamma-PNTM has been found to boost the immune systems’ response to flu vaccination when it is given at the same time as an influenza vaccine. Gamma-PNTM’s ability to do...